Modulight Biotherapeutics, developer of novel optogenetic platform for the treatment of neurological disorders, announced the closing of its Seed funding round raising $12.2 million. The Seed round was led by Jibe Ventures and LocalGlobe, with participation from Nexus Neurotech Ventures, RedSeed VC, Secret Chord Ventures, Fresh Fund, Saras Capital, SilverArc Capital and Sha'ar Mivnim. The funding will enable the Company to accelerate the development of its optogenetic technology platform and advance its therapeutic product pipeline towards the clinic.